This biotechnology company uses a combination of machine learning, artificial intelligence, and genomics to develop novel precision oncology therapeutics with a focus on prostate and lung cancer.
This biotechnology company uses a combination of machine learning, artificial intelligence, and genomics to develop novel precision oncology therapeutics with a focus on prostate and lung cancer.